CAS: 910297-61-9 - 5-Thiazolecarboxamide, 2,2′-[1,4-piperazinediylbis[(2-methyl-6,4-pyrimidinediyl)imino]]bis[N-(2-chloro-6-methylphenyl)-
Formula:C36H34Cl2N12O2S2
InChI:InChI=1S/C36H34Cl2N12O2S2/c1-19-7-5-9-23(37)31(19)47-33(51)25-17-39-35(53-25)45-27-15-29(43-21(3)41-27)49-11-13-50(14-12-49)30-16-28(42-22(4)44-30)46-36-40-18-26(54-36)34(52)48-32-20(2)8-6-10-24(32)38/h5-10,15-18H,11-14H2,1-4H3,(H,47,51)(H,48,52)(H,39,41,43,45)(H,40,42,44,46)
InChI key:InChIKey=QBKZXQDFDIASAL-UHFFFAOYSA-N
SMILES:O=C(NC=1C(Cl)=CC=CC1C)C=2SC(=NC2)NC3=NC(=NC(=C3)N4CCN(C=5N=C(N=C(C5)NC6=NC=C(S6)C(=O)NC=7C(Cl)=CC=CC7C)C)CC4)C
- Synonyms:
- 5-Thiazolecarboxamide, 2,2′-[1,4-piperazinediylbis[(2-methyl-6,4-pyrimidinediyl)imino]]bis[N-(2-chloro-6-methylphenyl)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Dasatinib Impurity 8 (Dasatinib Dimeric Impurity) REF: 4Z-D-3013CAS: 910297-61-9 | - - - | To inquire | Thu 21 Nov 24 | |
Dasatinib Dimeric Impurity REF: TR-D193620CAS: 910297-61-9 | - - - | 316.00 €~2,045.00 € | Mon 02 Dec 24 | |
Dasatinib dimeric impurity REF: 3D-KLB29761CAS: 910297-61-9 | Min. 95% | To inquire | Thu 02 Jan 25 |
Dasatinib Impurity 8 (Dasatinib Dimeric Impurity)
Ref: 4Z-D-3013
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Dasatinib Dimeric Impurity
Controlled ProductRef: TR-D193620
1mg | 316.00 € | ||
10mg | 2,045.00 € |
Dasatinib dimeric impurity
Ref: 3D-KLB29761
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |